Injectable tan crackdown
This article was originally published in The Tan Sheet
Executive Summary
The U.K.'s Medicines and Healthcare products Regulatory Agency advises Nov. 17 against using the unlicensed drug Melanotan, an injectable tan sold illegally as a nonprescription product on Web sites and in some gyms and tanning salons. Melanotan increases the body's melanin levels to create a tan, but the substance "has not been tested for safety, quality or effectiveness" in the U.K., MHRA says
You may also be interested in...
Sun Product Research Heats Up; U.K. Agency Warns About Unapproved OTC
As pharmaceutical firms work on injectable products that in the future could compete with sunscreens and suntan oils and lotions, health authorities in the U.K. warn that an unapproved drug marketed as "injectable tan" is being sold over the counter there
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.